European Bioinformatics Institute | EMBL-EBI
David Hulcoop currently serves as Executive Director of Open Targets at the European Bioinformatics Institute | EMBL-EBI, a position held since October 2023. Prior to this, David held several roles at GSK from October 2007 to October 2023, including Acting Director and Open Targets Strategy & Operations Director, overseeing strategies for drug target identification and drug discovery. David also contributed as Open Targets Operations Director in a partnership that included major pharmaceutical companies and research institutes. Additional experiences at GSK involve leadership in second generation process chemistry, technology transfer programs, and strategic project delivery for the CEO's office. David's academic background includes a PhD in Organic Chemistry from the University of Cambridge and post-doctoral research at the University of Toronto, focusing on synthetic chemistry and novel methodologies in pharmaceuticals.
This person is not in any teams
This person is not in any offices
European Bioinformatics Institute | EMBL-EBI
2 followers
Working at EMBL-EBI gives you the opportunity to focus your energy and skills on something that really matters: using technology to contribute to discoveries that benefit humankind. We empower researchers everywhere to realise the potential of ‘big data’ in biology, and build sophisticated tools for exploring life at the atomic level.